Marek Ancukiewicz

Marek Ancukiewicz, Ph.D. has a wealth of experience in biostatistics and has worked in various roles at prominent companies like Miltenyi Biomedicine, Agenus, LFB USA, Alnylam Pharmaceuticals, and PAREXEL. Ancukiewicz has also held academic positions at Harvard Medical School/Massachusetts General Hospital and Duke University. With a background in both academia and industry, Ancukiewicz has contributed significantly to the development of innovative therapies for cancer and hemophilia drugs.